Table 4.
Monotherapy vs. Combination Therapy.
| Monotherapy (n = 33) | |
| Colistin | 9 |
| Meropenem | 9 |
| Piperacillin/tazobactam | 6 |
| Tigecycline | 3 |
| Ceftriaxone | 3 |
| Imipenem/cilastatin | 2 |
| Ciprofloxacin | 1 |
| Combination Based (n = 40) | |
| Colistin-based combination | Total = 30 |
| Colistin + Meropenem | 10 |
| Colistin + Meropenem + Piperacillin/tazobactam | 6 |
| Colistin + Tigecycline | 5 |
| Colistin + Meropenem + Tigecycline | 5 |
| Colistin + Bactrim | 1 |
| Colistin + Gentamicin | 1 |
| Colistin + Ciprofloxacin + Piperacillin/tazobactam | 1 |
| Colistin + Imipenem/cilastatin + Piperacillin/tazobactam | 1 |
| Other combination | Total = 10 |
| Tigecycline + Gentamicin | 4 |
| Meropenem + Gentamicin | 2 |
| Meropenem + Vancomycin + Piperacillin/tazobactam | 1 |
| Meropenem + Ceftriaxone + Levofloxacin | 1 |
| Piperacillin/tazobactam + Ceftazidime | 1 |
| Piperacillin/tazobactam + Vancomycin + Ceftrixone | 1 |